| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/05/2009 | US20090036514 Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injury |
| 02/05/2009 | US20090036508 Amino indazole derivatives |
| 02/05/2009 | US20090036480 5-Ht7 Receptor Antagonists |
| 02/05/2009 | US20090036475 Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use |
| 02/05/2009 | US20090036474 Quinazoline derivatives for use against cancer |
| 02/05/2009 | US20090036472 Azabicyclo derivatives as anti-inflammatory agents |
| 02/05/2009 | US20090036465 Combination therapy for pulmonary arterial hypertension |
| 02/05/2009 | US20090036457 Utilities of olefin derivatives |
| 02/05/2009 | US20090036453 Pyrrolopyridazinone Compound |
| 02/05/2009 | US20090036449 Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors |
| 02/05/2009 | US20090036447 Compounds, Compositions and Methods |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/05/2009 | US20090036432 Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic |
| 02/05/2009 | US20090036429 Hydroxypiperidine Derivatives and Uses Thereof |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090036405 Method for blocking ligation of the receptor for advanced glycation end-products (rage) |
| 02/05/2009 | US20090036400 Pharmaceutical Preparations for Treating the Consequences of Alcohol Abuse, Hepatitis, Pancreatitis, Alzheimer's Disease, Parkinson's Disease, Diabetes, Toxic Kidney Disease, Reperfusion Damage, Arteriosclerosis, and as an Antidote Against Environmental Toxins and Medicinal Intoxication |
| 02/05/2009 | US20090036382 TGF-Beta Modulators and Use Thereof |
| 02/05/2009 | US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis |
| 02/05/2009 | US20090036373 a Wnt pathway stimulator and a Tie2 pathway repressor; polypeptides |
| 02/05/2009 | US20090036370 Leukocyte Adhesion Inhibitor-1 (LAI-1) |
| 02/05/2009 | US20090036355 Antisense Modulation of PTP1B Expression |
| 02/05/2009 | US20090036352 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 02/05/2009 | US20090035374 Method of making a single-stage pharmaceutical preparation for oral therapy to regulate blood pressure and kit containing same |
| 02/05/2009 | US20090035348 Dissolution of arterial plaque |
| 02/05/2009 | US20090035347 Isolated stromal cells and methods of using the same |
| 02/05/2009 | US20090035308 Methods for using and identifying modulators of Delta-like 4 |
| 02/05/2009 | US20090035291 Therapeutic use of adpase enhanced apyrases |
| 02/05/2009 | US20090035287 Atrial natriuretic peptide (anp) splice variants and methods of using same |
| 02/05/2009 | US20090035286 Intracoronary, intracardiac, or intravenous infusion of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium |
| 02/05/2009 | US20090035282 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 02/05/2009 | US20090035275 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of NAD |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | DE102008033254A1 Verfahren zur Herstellung eines einphasischen pharmazeutischen Präparates zur oralen Therapie der Regulierung des Blutdruckes A method for producing a pharmaceutical preparation for the oral therapy einphasischen the regulation of blood pressure |
| 02/05/2009 | DE102007036076A1 Dipeptoid-Produgs und ihre Verwendung Dipeptoid prodrugs and their use |
| 02/05/2009 | DE102007036075A1 Prodrugs und ihre Verwendung Prodrugs and their use |
| 02/05/2009 | CA2698170A1 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile |
| 02/05/2009 | CA2695259A1 Metabolites and derivatives of ambrisentan |
| 02/05/2009 | CA2695071A1 The use of benzamide derivatives for the treatment of cns disorders |
| 02/05/2009 | CA2694928A1 Micro-rnas that control myosin expression and myofiber identity |
| 02/05/2009 | CA2681021A1 Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2020411A1 Spiro tetracyclic compound |
| 02/04/2009 | EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 02/04/2009 | EP2020241A1 Cerebral vasospasm inhibitor |
| 02/04/2009 | EP2020235A1 Method for manufacturing a single-phase pharmaceutical preparation for oral treatment to regulate blood pressure |
| 02/04/2009 | EP2020232A1 N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/04/2009 | EP2020231A1 Fat absorption inhibitor |
| 02/04/2009 | EP2019720A2 Treating muscular disorders and improving muscular function |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | EP1414410B1 Nanoparticulate formulations of fenofibrate |
| 02/04/2009 | CN101360749A Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations |
| 02/04/2009 | CN101360499A Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 02/04/2009 | CN101357914A Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 02/04/2009 | CN101357901A Chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic carboxylate, preparation method and application thereof |
| 02/04/2009 | CN101357217A Traditional Chinese medicine formulation for treating coronary heart disease |
| 02/04/2009 | CN101357198A Traditional Chinese medicine for treating cerebral thrombus |
| 02/04/2009 | CN101357193A Traditional Chinese medicine for treating hypertension and hyperlipemia and its preparation method |
| 02/04/2009 | CN101357178A Traditional Chinese medicine composition for treating the cerebrovascular disease |
| 02/04/2009 | CN101357177A Traditional Chinese medicine for preventing and treating central serous chorioretinopathy and preparation method thereof |
| 02/04/2009 | CN101357173A Chinese herbal medicine compound preparation for treating hypertension |
| 02/04/2009 | CN101357162A Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis |
| 02/04/2009 | CN101357155A Medicine for treating apoplexy |
| 02/04/2009 | CN101357144A Selaginella uncinata extraction, its preparation method and application |
| 02/04/2009 | CN101357142A Use of Clostridium butyricum in preparing medicine composition for preventing and treating cerebrovascular disease |
| 02/04/2009 | CN101357136A Composition of traditional Chinese medicine effective constituent for preventing and treating diseased associated with cerebral ischemia injury |
| 02/04/2009 | CN101357127A Use of carthamus tinctorius yellow colour in preparing medicine for treating and/or preventing myocardial apoptosis |
| 02/04/2009 | CN101357125A Use of leonurine in preparing medicine for preventing and treating ischemic cardiomyopathy |
| 02/04/2009 | CN101357119A Medicine microemulsion injection composition and preparation method thereof |
| 02/04/2009 | CN101357117A Breviscapini injection and preparation method thereof |
| 02/04/2009 | CN101356980A Preparation method of fish liver hydrolysate and use thereof |
| 02/04/2009 | CN101356969A Health food containing pearl and kudzuvine root and its preparation method |
| 02/04/2009 | CN100459776C Access parameter adaptation and packet data resource management by utilizing detailed mobile status information |
| 02/04/2009 | CN100457897C Preparation process of and use of thrombus dissolving enzyme |
| 02/04/2009 | CN100457772C Ganoderma lucidum sterol extract and its preparation process and application |
| 02/04/2009 | CN100457757C Novel spiro compounds |
| 02/04/2009 | CN100457752C Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 02/04/2009 | CN100457720C 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 02/04/2009 | CN100457190C Promoters exhibiting endothelial cell specificity and methods of using same |
| 02/04/2009 | CN100457187C VEGF slowly releasing injection microsphere support and its preparation and use |
| 02/04/2009 | CN100457184C Multi-stage oral drug controlled-release system |
| 02/04/2009 | CN100457182C Behavior chemotherapy |
| 02/04/2009 | CN100457171C A preparation method of medicine for treating hemiparalysis caused by apoplexy |
| 02/04/2009 | CN100457162C Oral medicine for treating cerebral blood-supply deficiency giddiness and cava infarction and hyperthrombinemia |
| 02/04/2009 | CN100457134C Method for preparing extractive of Jumi |
| 02/04/2009 | CN100457132C Preparing method of fleabane extract dry matter |
| 02/04/2009 | CN100457131C Dripping pills of erigeron breviscapus and its preparation method |
| 02/04/2009 | CN100457130C Refined puncturevine fruit saponin capable of being administered by injection, its preparing process and injecta |
| 02/04/2009 | CN100457129C Blood-block unlock freeze-dried powder injection(including special solvent), technique and adaptive disease |
| 02/04/2009 | CN100457128C Drop pills for treating coronary heart disease, angina pectoris and preparation method thereof |
| 02/04/2009 | CN100457108C Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 02/04/2009 | CN100457103C Double layer osmotic pump controlled release felodipine medicine composition |
| 02/04/2009 | CN100457102C Pharmaceutical compositions |
| 02/04/2009 | CN100457101C Propylgallate injection with favorable solubility and its preparation process |
| 02/04/2009 | CN100457099C Hemorrhoid injection |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |